95 related articles for article (PubMed ID: 25217554)
21. Concentrations of unconjugated morphine, codeine and 6-acetylmorphine in urine specimens from suspected drugged drivers.
Ceder G; Jones AW
J Forensic Sci; 2002 Mar; 47(2):366-8. PubMed ID: 11908609
[TBL] [Abstract][Full Text] [Related]
22. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.
Teixeira H; Verstraete A; Proença P; Corte-Real F; Monsanto P; Vieira DN
Forensic Sci Int; 2007 Aug; 170(2-3):148-55. PubMed ID: 17614225
[TBL] [Abstract][Full Text] [Related]
23. A rapid and sensitive method for the identification of delta-9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
Molnar A; Lewis J; Doble P; Hansen G; Prolov T; Fu S
Forensic Sci Int; 2012 Feb; 215(1-3):92-6. PubMed ID: 21367546
[TBL] [Abstract][Full Text] [Related]
24. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.
Heltsley R; Depriest A; Black DL; Crouch DJ; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
J Anal Toxicol; 2012 Mar; 36(2):75-80. PubMed ID: 22337775
[TBL] [Abstract][Full Text] [Related]
25. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases.
Choi H; Baeck S; Jang M; Lee S; Choi H; Chung H
Forensic Sci Int; 2012 Feb; 215(1-3):81-7. PubMed ID: 21377815
[TBL] [Abstract][Full Text] [Related]
27. Determination of carisoprodol and meprobamate in oral fluid.
Coulter C; Garnier M; Tuyay J; Orbita J; Moore C
J Anal Toxicol; 2012 Apr; 36(3):217-20. PubMed ID: 22417839
[TBL] [Abstract][Full Text] [Related]
28. Screening of synthetic cannabinoids in preserved oral fluid by UPLC-MS/MS.
Oiestad EL; Johansen U; Christophersen AS; Karinen R
Bioanalysis; 2013 Sep; 5(18):2257-68. PubMed ID: 24053241
[TBL] [Abstract][Full Text] [Related]
29. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
Cone EJ
Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
[TBL] [Abstract][Full Text] [Related]
30. Development of an LC-MS/MS method for the simultaneous determination of 25 benzodiazepines and zolpidem in oral fluid and its application to authentic samples from regular drug users.
Jang M; Chang H; Yang W; Choi H; Kim E; Yu BH; Oh Y; Chung H
J Pharm Biomed Anal; 2013 Feb; 74():213-22. PubMed ID: 23245253
[TBL] [Abstract][Full Text] [Related]
31. Selection of an immunoassay screening cutoff concentration for opioids in oral fluid.
Garnier M; Coulter C; Moore C
J Anal Toxicol; 2011 Jul; 35(6):369-74. PubMed ID: 21740695
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a method for the quantitation of Delta9tetrahydrocannabinol in oral fluid by liquid chromatography electrospray-mass-spectrometry.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):319-24. PubMed ID: 15380731
[TBL] [Abstract][Full Text] [Related]
33. Detection of phencyclidine in human oral fluid using solid-phase extraction and liquid chromatography with tandem mass spectrometric detection.
Coulter C; Crompton K; Moore C
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):123-8. PubMed ID: 18243825
[TBL] [Abstract][Full Text] [Related]
34. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid.
Wylie FM; Torrance H; Anderson RA; Oliver JS
Forensic Sci Int; 2005 Jun; 150(2-3):191-8. PubMed ID: 15944059
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC-MS-MS.
Truver MT; Swortwood MJ
J Anal Toxicol; 2018 Oct; 42(8):554-561. PubMed ID: 30371839
[TBL] [Abstract][Full Text] [Related]
36. Performance of a point-of-care device for oral fluid ketamine evaluated by a liquid chromatography-tandem mass spectrometry method.
Tsui TK; Chan AS; Lo CW; Wong A; Wong RC; Ho CS
J Anal Toxicol; 2012 Apr; 36(3):210-6. PubMed ID: 22417838
[TBL] [Abstract][Full Text] [Related]
37. Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid.
Simões SS; Ajenjo AC; Franco JM; Vieira DN; Dias MJ
Rapid Commun Mass Spectrom; 2009 May; 23(10):1451-60. PubMed ID: 19350524
[TBL] [Abstract][Full Text] [Related]
38. Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device.
Wiesen MH; Farowski F; Feldkötter M; Hoppe B; Müller C
J Chromatogr A; 2012 Jun; 1241():52-9. PubMed ID: 22552204
[TBL] [Abstract][Full Text] [Related]
39. Quantification of selected synthetic cannabinoids and Δ9-tetrahydrocannabinol in oral fluid by liquid chromatography-tandem mass spectrometry.
de Castro A; Piñeiro B; Lendoiro E; Cruz A; López-Rivadulla M
J Chromatogr A; 2013 Jun; 1295():99-106. PubMed ID: 23680386
[TBL] [Abstract][Full Text] [Related]
40. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid.
Cooper G; Wilson L; Reid C; Hand C; Spiehler V
Forensic Sci Int; 2006 Jun; 159(2-3):104-12. PubMed ID: 16115742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
